Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure

Sodium–glucose cotransporter-2 inhibitors (SGLT2is) are a relatively new class of antidiabetic drugs that have shown favorable effects in heart failure (HF) patients, irrespective of the left ventricular ejection fraction (LVEF). Recent studies have demonstrated the beneficial effects of empaglifloz...

Descripción completa

Detalles Bibliográficos

Autores principales:	Andrew Xanthopoulos, Nikolaos Katsiadas, Spyridon Skoularigkis, Dimitrios E. Magouliotis, Niki Skopeliti, Sotirios Patsilinakos, Alexandros Briasoulis, Filippos Triposkiadis, John Skoularigis
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2023-08-01
Colección:	Life
Materias:	sodium glucose cotransporter-2 inhibitors dapagliflozin remodeling diabetes mellitus heart failure
Acceso en línea:	https://www.mdpi.com/2075-1729/13/8/1778
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!